glp 1 drugs fda approved GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Hims & Hers stock falls

Cons Mixed reviews regarding their customer service

In a study published in JAMA Network Open in January 2025, which included more than 125,000 patients, nearly 65 percent of those taking GLP1s for reasons other than Type 2 diabetes discontinued them within one year

Pharmaceutical Benefits Scheme (PBS)

Stopping any of these medications abruptly can lead to rebound hunger, blood sugar fluctuations, and weight regain

Keywords: Glucagon-like peptide 1 receptor agonists, Dermatology, Plastic surgery, Safety, Drug side effects Key Summary Points Introduction Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have revolutionized the treatment landscape for type 2 diabetes mellitus (T2DM) and obesity, offering significant benefits in glycemic control, weight reduction, and cardiometabolic protection